In the US, Simulect (basiliximab systemic) is a member of the drug class interleukin inhibitors and is used to treat Organ Transplant, Rejection Prophylaxis.
Ingredient matches for Simulect
Basiliximab is reported as an ingredient of Simulect in the following countries:
- Croatia (Hrvatska)
- Czech Republic
- Hong Kong
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.